Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test

Test material

Reference
Name:
Unnamed
Type:
Constituent

In vivo test system

Test animals

Species:
guinea pig
Strain:
Hartley
Sex:
female
Details on test animals and environmental conditions:
Hartley strain albino

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
other: liquid paraffin (intradermal induction); see also under concentration (next box)
Concentration / amount:
Intradermal induction: 0.1 ml of the test formulation (a. 10w/w%; b. 1:1 emulsion of 20w/w% test formulation (test article mixed with FCA) and saline; c. 100% test item)
Topical induction: 0.2 ml of the test formulation (a. 10w/w%; b. 1:1 emulsion of 20w/w% test formulation (test article mixed with FCA) and saline; c. 100% test item) --> exposure for 48 hrs
Challenge: a. 0.1 ml of the test formulations at two concentrations (100% and 50 w/w% in polyethylene glycol 300) --> exposure for 24 hrs

Intradermal dosing: Day 1
Induction dosing: Day 1 + 6
Challenge dosing: Day 1 + 20
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
other: liquid paraffin (intradermal induction); see also under concentration (next box)
Concentration / amount:
Intradermal induction: 0.1 ml of the test formulation (a. 10w/w%; b. 1:1 emulsion of 20w/w% test formulation (test article mixed with FCA) and saline; c. 100% test item)
Topical induction: 0.2 ml of the test formulation (a. 10w/w%; b. 1:1 emulsion of 20w/w% test formulation (test article mixed with FCA) and saline; c. 100% test item) --> exposure for 48 hrs
Challenge: a. 0.1 ml of the test formulations at two concentrations (100% and 50 w/w% in polyethylene glycol 300) --> exposure for 24 hrs

Intradermal dosing: Day 1
Induction dosing: Day 1 + 6
Challenge dosing: Day 1 + 20
No. of animals per dose:
5 (control group) and 10 (test item sensitization group)

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
100% and 50 w/w%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no abnormal clinical signs in any animal in any group
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100% and 50 w/w%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no abnormal clinical signs in any animal in any group.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
100% and 50 w/w-%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no abnormal clinical signs in any animal in any group
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100% and 50 w/w-%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no abnormal clinical signs in any animal in any group.
Reading:
1st reading
Hours after challenge:
24
Group:
other: control group
Dose level:
100% and 50 w/w-%
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no abnormal clinical signs in any animal in any group
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: control group. Dose level: 100% and 50 w/w-%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no abnormal clinical signs in any animal in any group.
Reading:
2nd reading
Hours after challenge:
48
Group:
other: control group
Dose level:
100% and 50 w/w-%
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no abnormal clinical signs in any animal in any group
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: control group. Dose level: 100% and 50 w/w-%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no abnormal clinical signs in any animal in any group.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information
Conclusions:
The test item was judged to have no sensitization potential.